A structured framework for implant risk assessment

Researchers have validated a new implant prognosis system that integrates multiple clinical and systemic factors to predict medium-term implant survival. Unlike earlier models focused solely on bone loss or disease stage, the Kwok et al. system evaluates plaque control, implant position, restoration design, periodontal history, supportive care, smoking, diabetes, osteoporosis, antiresorptive medicines, radiotherapy, occlusion and genetic factors. Implants are classified into four prognostic categories: favourable, questionable, unfavourable and hopeless.

Clinical validation shows clear risk stratification

A retrospective analysis of 651 implants in 291 patients over five years demonstrated the system's predictive capacity. Implants with a favourable baseline prognosis achieved 100% survival, compared with 93.5% in the questionable group and 33.3% in the unfavourable category. Baseline prognosis remained unchanged for 95.7% of favourable cases, 78.5% of questionable cases and 33.3% of unfavourable cases over the study period. The model showed stronger predictive reliability for mandibular implants than maxillary implants, with anterior and premolar sites in the mandible more consistently assessed than molar sites. In the maxilla, prognosis was reliably predictive only for central incisors.

Framework has potential but requires refinement

The authors acknowledge the system may be incomplete and suggest future versions consider implant phenotype, detailed prosthetic factors, mandibular versus maxillary location, and antidepressant use as possible prognostic modifiers. The structured approach allows clinicians to stratify patient risk, identify high-risk cases earlier and communicate treatment outcomes more accurately. The study was published online 6 March 2026 in the Journal of Periodontology.